A detailed history of Cim Investment Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cim Investment Management Inc holds 15,174 shares of BMY stock, worth $824,251. This represents 0.2% of its overall portfolio holdings.

Number of Shares
15,174
Previous 15,315 0.92%
Holding current value
$824,251
Previous $830,000 24.1%
% of portfolio
0.2%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$40.25 - $52.99 $5,675 - $7,471
-141 Reduced 0.92%
15,174 $630,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $19,335 - $21,619
-334 Reduced 2.13%
15,315 $888,000
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $1,975 - $2,192
31 Added 0.2%
15,649 $1 Million
Q1 2023

May 16, 2023

BUY
$65.71 - $74.53 $405,102 - $459,477
6,165 Added 65.22%
15,618 $1.08 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $683,772 - $809,683
-9,985 Reduced 51.37%
9,453 $680,000
Q2 2022

Sep 02, 2022

SELL
$72.62 - $79.98 $7,552 - $8,317
-104 Reduced 0.53%
19,438 $1.5 Million
Q1 2022

May 17, 2022

SELL
$61.48 - $73.72 $87,117 - $104,461
-1,417 Reduced 6.76%
19,542 $1.43 Million
Q4 2021

May 19, 2022

SELL
$53.63 - $62.52 $1.14 Million - $1.33 Million
-21,326 Reduced 50.43%
20,959 $1.31 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $1.12 Million - $1.31 Million
20,959 Added 98.28%
42,285 $2.57 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $6,804 - $7,970
-115 Reduced 0.54%
21,326 $1.26 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $25,630 - $27,911
-414 Reduced 1.89%
21,441 $1.43 Million
Q1 2021

May 20, 2021

SELL
$59.34 - $66.74 $45,573 - $51,256
-768 Reduced 3.39%
21,855 $1.38 Million
Q4 2020

Feb 17, 2021

BUY
$57.74 - $65.43 $446,618 - $506,101
7,735 Added 51.95%
22,623 $1.4 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $8,384 - $9,291
-146 Reduced 0.97%
14,888 $898,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $824,163 - $963,529
15,034 New
15,034 $884,000
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $377,785 - $492,786
-7,677 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $33,873 - $40,162
-792 Reduced 9.35%
7,677 $389,000
Q2 2019

Aug 08, 2019

BUY
$44.62 - $49.34 $15,081 - $16,676
338 Added 4.16%
8,469 $384,000
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $367,321 - $437,985
-8,141 Reduced 50.03%
8,131 $388,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $31,694 - $41,099
-650 Reduced 3.84%
16,272 $846,000
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $441 - $498
-8 Reduced 0.05%
16,922 $1.05 Million
Q2 2018

Aug 07, 2018

BUY
$50.53 - $62.98 $534,354 - $666,013
10,575 Added 166.4%
16,930 $937,000
Q1 2018

May 10, 2018

BUY
$59.92 - $68.98 $380,791 - $438,367
6,355 New
6,355 $402,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.